When business operations are resumed in times of the Corona pandemic, safety and health protection have top priority. For this reason, the nationwide occupational health and safety standard COVID-19 has been in force since April 16, 2020.
Cardiovascular diseases are still one of the most frequent causes of death in Germany. Aristo Pharma offers a wide range of relevant active ingredients for different therapeutic requirements.
With its new website https://www.herzkreislaufexperte.de, Aristo Pharma now supports specialist groups with information on current topics relating to cardiovascular diseases. The focus is on the possibility of therapy using modern active ingredients and fixed combinations.
Here, physicians can exchange information with experts from Aristo Pharma's medical department and ask therapeutically relevant questions. In addition, members of the specialist group can download information on current training opportunities as well as subject-relevant service materials and case studies.